Stop Foreign Inflow into Hospitals, Curb Buyouts: Parliament Panel Demands Price Caps to Save Cheap Helathcare

A Parliamentary Standing Committee has urged the Union government to immediately restrict foreign direct investment in private hospitals, warning that an uncontrolled wave of foreign capital is pricing millions of Indians out of basic medical care.

The panel’s report singles out global private equity firms, which have injected roughly $10 billion into Indian hospital chains over the past five years. Lawmakers cautioned that this aggressive financial expansion is turning essential medical treatment into a high-yield profit engine, effectively converting community healthcare into a purely capitalistic enterprise.

Foreign Funds Buying Up Affordable Mid-Sized Hospitals

Instead of deploying capital to construct new greenfield hospitals in rural or underserved regions facing severe bed shortages, global funds have focused on buying existing, budget-friendly private hospitals. Large corporate networks then consolidate these independent units into centralized, high-margin chains.

"The growing presence of foreign capital in private hospital chains is facilitating the acquisition of cost-effective, mid-sized hospitals by larger corporate entities," the committee stated in its report.

This takeover model hits middle- and low-income families hardest. Once standalone local hospitals join private equity portfolios, room charges, diagnostic fees, and surgical costs escalate rapidly to deliver the double-digit returns expected by international investors.

Panel Recommends FDI Policy Overhaul and Mandatory Price Caps

To stem medical inflation running as high as 13% annually, the parliamentary committee recommended that foreign and private capital act strictly as a supplement to state health spending, rather than a replacement.

Key recommendations submitted to the Union government include:

• Restricting FDI in Brownfield Assets: Overhauling foreign direct investment norms so global funds are forced to build new facilities rather than acquire established, low-cost hospitals.

• Capping Hospital Tariffs: Enforcing legal price ceilings on hospital room tariffs, surgical procedures, and diagnostic testing.

• Creating an Independent Sector Regulator: Establishing an official watchdog to penalize excessive markups on medicines and compel hospitals to publish clear, itemized price lists before patient admission.

• Reserving Subsidised Beds: Ordering corporate hospital chains to reserve a fixed share of beds at regulated rates for economically weaker sections.

Wall Street Funds Resistance Against Price Regulations

Private equity-backed hospital chains control under 5% of total hospital beds across India, but they maintain dominant control over lucrative tertiary specialties such as cardiology, oncology, and robotic surgery. Official data shows treatment in these corporate facilities routinely costs five to ten times more than in public hospitals.

Global investment funds—including firms like Blackstone, KKR, TPG, General Atlantic, and EQT Group—have resisted calls for strict government price controls. Representatives from major private equity funds warned that imposing tariff caps would undermine India's broader economic deregulation and freeze future capital commitments toward modernizing medical infrastructure.

However, committee members argue that without firm limits on foreign buyouts and mandatory tariff controls, India's vast "missing middle"—citizens who do not qualify for state welfare schemes like Ayushman Bharat yet lack the financial resources to pay corporate hospital rates—will be locked out of essential healthcare.